pramipexole has been researched along with 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane in 4 studies
| Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) | Studies (2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane) | Trials (2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane) | Recent Studies (post-2010) (2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane) |
|---|---|---|---|---|---|
| 1,103 | 219 | 517 | 845 | 47 | 566 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jennings, D; Marek, K; Seibyl, J | 1 |
| Cannas, A; Floris, G; Marrosu, F; Marrosu, MG; Piga, M; Serra, A; Solla, P; Tacconi, P | 1 |
| Béhé, M; Depboylu, C; Hermanns, G; Höglinger, GU; Matusch, A; Maurer, L; Oertel, WH; Windolph, A | 1 |
| Han, J; Lee, BJ; Park, D; Yu, KJ | 1 |
1 review(s) available for pramipexole and 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane
| Article | Year |
|---|---|
Do dopamine agonists or levodopa modify Parkinson's disease progression?
Topics: Animals; Antiparkinson Agents; Benzothiazoles; Carrier Proteins; Dihydroxyphenylalanine; Disease Progression; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Humans; Indoles; Iodine Radioisotopes; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Neostriatum; Nerve Tissue Proteins; Parkinson Disease; Pramipexole; Radiopharmaceuticals; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Tropanes | 2002 |
3 other study(ies) available for pramipexole and 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane
| Article | Year |
|---|---|
Reversible Pisa syndrome in patients with Parkinson's disease on dopaminergic therapy.
Topics: Aged; Aged, 80 and over; Benserazide; Benzothiazoles; Brain; Carbidopa; Dopamine Agents; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Time Factors; Tomography, Emission-Computed, Single-Photon; Tropanes | 2009 |
Effect of long-term treatment with pramipexole or levodopa on presynaptic markers assessed by longitudinal [123I]FP-CIT SPECT and histochemistry.
Topics: Animals; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Levodopa; Longitudinal Studies; Male; Mice; Mice, Inbred C57BL; Neuronal Plasticity; Parkinson Disease; Pramipexole; Presynaptic Terminals; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Tropanes | 2013 |
Usefulness of F-18 FP-CIT PET to predict dopamine-responsive hand tremor in patients other than Parkinson's disease: Two case reports.
Topics: Aged; Basal Ganglia; Benzothiazoles; Brain Injuries, Traumatic; Dopamine; Dopamine Agonists; Female; Hemiplegia; Humans; Male; Positron-Emission Tomography; Pramipexole; Tremor; Tropanes | 2018 |